CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Rhone-Poulenc Rorer

For profit
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Mar 1, 1999

Last known activity

Mar 1, 2000

Acquired by Aventis → Sanofi-Synthelabo → Sanofi-Aventis on Jan 1, 1999

Timeline

1990s

  1. Jan 1, 1990

    Rhone-Poulenc Rorer— Founded

  2. Jan 1, 1990

    Rhone Poulenc— Acquired

  3. Jan 1, 1990

    Rorer— Acquired

  4. Jan 1, 1995

    Fisons— Acquired

  5. Oct 23, 1995

    Applied Immunesciences— Acquired

  6. Jan 1, 1999

    Aventis— Acquired By

2000s

  1. Jan 1, 2004

    Sanofi-Aventis— Now

Drugs by trial phase (24 distinct, 27 trials)

Phase 4 (0 own, 1 via acquisition)

Phase 3 (0 own, 2 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 3 via acquisition)

Indications

Studied for

Subsidiaries (4 direct, 15 total across the full acquisition tree)

Recent trials (4)

Details

Founded
Strasbourg, FR Jan 1, 1990
Last known activity
Mar 1, 2000